Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

Name: Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
License: Public Domain

Mayo Clinic

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

autosomal dominant polycystic kidney disease, nephrogenic diabetes insipidus, acquired nephrogenic diabetes insipidus, congenital nephrogenic diabetes insipidus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 226200
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.